The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of abiraterone acetate (AA) and enzalutamide (EZ) administration on chemotherapy-naïve metastatic castration-resistant prostate cancer (CN-mCRPC) patient’s symptom burden.
 
Sepehr Salem
No Relationships to Disclose
 
Maria Komisarenko
No Relationships to Disclose
 
Narhari Timilshina
No Relationships to Disclose
 
Frank Jiao
No Relationships to Disclose
 
Ruby Grewal
No Relationships to Disclose
 
Shabbir M.H. Alibhai
No Relationships to Disclose
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Baxter; Bristol-Myers Squibb; Gilead Sciences; Merck; Novo Nordisk; Pfizer; Sanofi; Teva
Honoraria - Amgen; Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen Oncology